Abstract
ObjectivesAlthough there are 14 097 board-certified cardiologists in Japan, it is unknown whether the number of institutional board-certified cardiologists is related to the prognosis of cardiovascular disease patients.DesignCross-sectional analysis.SettingData were collected from the nationwide database of acute care hospitals in Japan (2371 hospitals) between 2012 and 2013.ParticipantsA total of 1 422 703 consecutive patients were initially included in this study, but 518 610 patients were excluded due to age <18 years, missing data or prior hospitalisations; therefore, 896 171 patients comprised the final sample population.Main outcome measuresThe primary outcome was in-hospital mortality due to any cause. For the per-hospital analysis, Poisson regression models were used to estimate the association of board-certified cardiologists with in-hospital mortality, adjusted for hospital facilitation. For the per-patient analysis, hierarchical logistic regression models were used to estimate the ORs of the number of institutional board-certified cardiologists, adjusted for patient demographics, diagnoses, therapies and hospital facilities.ResultsThe regression model of the per-hospital analysis indicated that the number of board-certified cardiologists was associated with a lower rate ratio of in-hospital mortality (rate ratio, 0.988; 95% CI 0.983 to 0.993; p<0.01). The per-patient analysis indicated that the median age was 73 years and the in-hospital mortality rate was 11.7%. The regression model indicated that the presence of more board-certified cardiologists was associated with a lower risk of in-hospital mortality (OR, 0.980; 95% CI 0.975 to 0.986; p<0.01) after adjustments for hospital facilities, patient characteristics and treatments.ConclusionsAmong cardiovascular disease patients admitted to acute care hospitals in Japan, the presence of more board-certified cardiologists was associated with a lower risk of in-hospital mortality. These results have implications for national and institutional strategies for determining the required number of board-certified cardiologists.
Funder
Shionogi
Abbott Japan
Astellas Pharma Inc
Takeda Pharmaceutical Company
Dainippon Sumitomo Pharma
Teijin Pharma
Novartis Pharmaceuticals Corporation
Kyowa Hakko Kirin
Actelion Pharmaceuticals Japan Ltd
St. Jude Medical
Endowed department by MSD K.K
Daiichi Sankyo Company
Otsuka Pharmaceutical
Mitsubishi Tanabe Pharma Corporation
Sanofi. Co. Ltd
Boehringer Ingelheim
Ono Pharmaceutical
Terumo
Pfizer Japan
Kowa Pharmaceutical
Bayer Holding
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献